Trial Profile
Randomized Clinical Trial to Evaluate The Effect of Metformin-GLP-1 Receptor Agonist Versus Oral Contraceptive (OC) Therapy on Reproductive Disorders and Cardiovascular Risks in Overweight Polycystic Ovarian Syndrome (PCOS) Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Dec 2023
Price :
$35
*
At a glance
- Drugs Exenatide (Primary) ; Liraglutide (Primary) ; Metformin (Primary) ; Ethinylestradiol/cyproterone
- Indications Polycystic ovary syndrome
- Focus Therapeutic Use
- 07 Nov 2023 Status changed from recruiting to completed.
- 03 Dec 2018 Planned primary completion date changed from 1 Oct 2018 to 3 Dec 2018.
- 17 Feb 2018 Planned End Date changed from 31 Dec 2017 to 31 Dec 2018.